In fact, in a mouse model of mild CKD, either ablation of TGFα, inhibition of EGFR activation, or inhibition of ADAM17 markedly reduced the degree of renal injury in response to a prolonged exposure to high levels of angiotensin II, despite persistent hypertension. This evidence concerns the gene TGFA and chronic kidney disease.